Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis, Lancet. Lond. Engl, vol.382, pp.1329-1340, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00925590
Epidemiology of peripheral artery disease, Circ. Res, vol.116, pp.1509-1526, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01233163
Evaluation of walking capacity over time in 500 patients with intermittent claudication who underwent clinical treatment, Arch. Intern. Med, vol.163, pp.2296-2300, 2003. ,
Inter-society consensus for the management of peripheral arterial disease (TASC II), Eur. J. Vasc. Endovasc. Surg. Off. J. Eur. Soc. Vasc. Surg, vol.33, pp.1-75, 2007. ,
Peripheral arterial disease detection, awareness, and treatment in primary care, JAMA, vol.286, pp.1317-1324, 2001. ,
Edinburgh artery study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population, Int. J. Epidemiol, vol.20, pp.384-392, 1991. ,
Exertional leg symptoms other than intermittent claudication are common in peripheral arterial disease, Arch. Intern. Med, vol.159, pp.387-392, 1999. ,
Asymptomatic peripheral arterial disease is independently associated with impaired lower extremity functioning: the women's health and aging study, Circulation, vol.101, pp.1007-1012, 2000. ,
Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment, JAMA, vol.286, pp.1599-1606, 2001. ,
Prognostic value of functional performance for mortality in patients with peripheral artery disease, J. Am. Coll. Cardiol, vol.51, pp.1482-1489, 2008. ,
Themes that determine quality of life in patients with peripheral arterial disease: a systematic review, The Patient, vol.11, issue.5, pp.489-502, 2018. ,
Functional impairment in peripheral artery disease and how to improve it in 2013, Curr. Cardiol. Rep, vol.15, p.347, 2013. ,
ESC guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the task force on the diagnosis and treatment of peripheral artery diseases of the European Society of Cardiology (ESC), Eur. Heart J, vol.32, pp.2851-2906, 2011. ,
Cilostazol for intermittent claudication, Cochrane Database Syst. Rev, issue.10, p.3748, 2014. ,
Phosphodiesterase 5 inhibitors-drug design and differentiation based on selectivity, pharmacokinetic and efficacy profiles, Curr. Pharm. Des, vol.12, pp.3459-3465, 2006. ,
Sildenafil and phosphodiesterase-5 inhibitors for heart failure, Curr. Heart Fail. Rep, vol.5, pp.110-114, 2008. ,
Therapeutic potential of phosphodiesterase 5 inhibition for cardiovascular disease, Circulation, vol.108, pp.239-244, 2003. ,
Sildenafil improves skeletal muscle oxygenation during exercise in men with intermittent claudication, Am. J. Phys. Regul. Integr. Comp. Phys, vol.307, pp.396-404, 2014. ,
, Vascular Pharmacology, p.106563, 2019.
, claudication improved with sildenafil: a case report, p.6186, 2017.
Improvement in symptoms of peripheral arterial disease with sildenafil therapy, Scott. Med. J, vol.58, pp.7-9, 2013. ,
NO/cGMP production is important for the endogenous peripheral control of hyperalgesia during inflammation, Nitric Oxide Biol. Chem, vol.28, pp.8-13, 2013. ,
Sildenafil improves microvascular O2 delivery-to-utilization matching and accelerates exercise O2 uptake kinetics in chronic heart failure, Am. J. Physiol. Heart Circ. Physiol, vol.303, pp.1474-1480, 2012. ,
Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association, Circulation, vol.126, pp.2890-2909, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00921590
Transcutaneous oxygen pressure measurements on the buttocks during exercise to detect proximal arterial ischemia: comparison with arteriography, Circulation, vol.107, pp.1896-1900, 2003. ,
Internal iliac artery stenosis: diagnosis and how to manage it in 2015, Front Cardiovasc, p.33, 2015. ,
Application of exercise transcutaneous oxygen pressure measurements for detection of proximal lower extremity arterial disease: a case report, Vasc. Med. Lond. Engl, vol.20, pp.251-255, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01134269
Exercise transcutaneous oxygen pressure measurement has good sensitivity and specificity to detect lower extremity arterial stenosis assessed by computed tomography angiography, Medicine (Baltimore), vol.95, p.4522, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01397595
Exercise treadmill testing in patients with claudication, with and without diabetes, Diabet. Med. J. Br. Diabet Assoc, vol.28, pp.356-362, 2011. ,
Bioequivalence study of a new sildenafil 100 mg orodispersible film compared to the conventional film-coated 100 mg tablet administered to healthy male volunteers, Drug. Des. Devel. Ther, vol.11, pp.1183-1192, 2017. ,
PDE5 inhibitors -pharmacology and clinical applications 20 years after sildenafil discovery, Br. J. Pharmacol, vol.175, pp.2554-2565, 2018. ,
Cardiovascular safety of phosphodiesterase type 5 inhibitors after nearly 2 decades on the market, Sex Med. Rev, vol.6, issue.4, pp.583-594, 2018. ,
Reliability of treadmill testing in peripheral arterial disease: a metaregression analysis, J. Vasc. Surg, vol.50, pp.322-329, 2009. ,
Roles of adenosine receptor subtypes on the antinociceptive effect of sildenafil in rat spinal cord, Neurosci. Lett, vol.480, pp.182-185, 2010. ,
Tadalafil analgesia in experimental arthritis involves suppression of intra-articular TNF release, Br. J. Pharmacol, vol.164, pp.828-835, 2011. ,
efficacy of daily lowdose sildenafil for treating interstitial cystitis: results of a randomized, double-blind, placebo-controlled trial-treatment of interstitial cystitis/painful bladder syndrome with low-dose sildenafil, Urology, vol.84, pp.51-56, 2014. ,
The effects of sildenafil on rectal sensitivity and tone in patients with the irritable bowel syndrome, Aliment. Pharmacol. Ther, vol.35, pp.577-586, 2012. ,
Near-infrared spectroscopy grades the severity of intermittent claudication in diabetics more accurately than ankle pressure measurement, Br. J. Surg, vol.87, pp.459-466, 2000. ,
An objective assessment of intermittent claudication by near-infrared spectroscopy, Eur. J. Vasc. Surg, vol.8, pp.294-296, 1994. ,
Near infrared brain and muscle oximetry: from the discovery to current applications, J. Infrared. Spectrosc. [Internet], vol.20, pp.1-14, 2012. ,
The protective effects of a phosphodiesterase 5 inhibitor, sildenafil, on postresuscitation cardiac dysfunction of cardiac arrest: metabolic evidence from microdialysis, Crit. Care Lond. Engl, vol.18, p.641, 2014. ,
ACC/ AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease, American College of Cardiology/American Heart Association, vol.33, pp.273-282, 1999. ,
Acute effects of a single dose of phosphodiesterase type 5 inhibitor (sildenafil) on systemic arterial blood pressure during exercise and 24-hour ambulatory blood pressure monitoring in heart transplant recipients, Transplant. Proc, vol.39, pp.3142-3149, 2007. ,
Effects of sildenafil citrate (Viagra) on hemodynamic parameters during exercise testing and occurrence of ventricular arrhythmias in patients with erectile dysfunction and cardiovascular disease, Eur. Urol, vol.43, pp.544-551, 2003. ,
Blood pressure in patients with intermittent claudication increases continuously during walking, Eur. J. Vasc. Endovasc. Surg. Off. J. Eur. Soc. Vasc. Surg, vol.33, pp.20-25, 2007. ,
Usefulness of hypertensive blood pressure response during a single-stage exercise test to predict long-term outcome in patients with peripheral arterial disease, Am. J. Cardiol, vol.102, pp.921-926, 2008. ,
Pharmacology and drug interaction effects of the phosphodiesterase 5 inhibitors: focus on alpha-blocker interactions, Am. J. Cardiol, vol.96, pp.42-46, 2005. ,
Association of lower extremity performance with cardiovascular and all-cause mortality in patients with peripheral artery disease: a systematic review and meta-analysis, J. Am. Heart Assoc, vol.3, 2014. ,
, Vascular Pharmacology, vol.118, p.106563, 2019.